首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1573716

生命科學分析市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Life Science Analytics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月27日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球生命科學分析市場估值為 157 億美元，預計 2024 年至 2032 年複合年成長率為 8.2%，這主要得益於臨床試驗中分析解決方案的日益採用以及個性化藥物的需求。

一個關鍵促進因素是在臨床試驗中擴大使用分析解決方案，解決臨床研究日益複雜的問題。這些解決方案提供即時見解、完善試驗設計並增強決策能力，從而產生更有效的結果。例如，Pharma Intelligence 2023 年的一項研究發現，65% 使用進階分析的臨床試驗申辦者的試驗效率提高了 25%，包括更快的患者招募和更精確的資料分析。

技術創新正在提高生命科學分析的效率。人工智慧和機器學習整合完善了預測建模和資料解釋，可以對大量資料集進行細緻分析，並揭示影響藥物開發和個人化治療策略的模式。

整個生命科學分析產業根據組件、類型、應用程式、部署模式、最終用途和區域進行分類。

服務領域在 2023資料以 91 億美元的收入引領市場。服務提供者設計、實施和管理這些解決方案，提供持續的支援、更新和維護，以確保最佳效能，促進該細分市場的成長。

2023 年，銷售和行銷支援部門以 36 億美元的收入位居營收榜首。生命科學公司依靠分析來衡量市場趨勢、了解客戶行為並評估競爭動態。銷售和行銷分析的洞察力使公司能夠制定有針對性的行銷策略、完善銷售方法並發現新興市場機會。個人化、數據驅動的行銷增強了客戶參與度並提高了轉換率，從而推動了該細分市場的成長。

2023 年，北美以 670 萬美元的收入主導生命科學分析市場，預計 2024 年至 2032 年複合年成長率為 7.7%。提供者和生命科學公司利用資料分析來做出更好的決策和改善患者的治療結果。北美在研發方面的大量投資，特別是在生物技術和製藥方面，擴大了對促進創新和簡化藥物開發的分析工具的需求。

產業生態系統分析
產業影響力
- 成長動力
  - 在臨床試驗中擴大採用分析解決方案
  - 對個人化藥物的需求不斷成長
  - 分析在生命科學產業的滲透率不斷提高
  - 分析解決方案技術進步的崛起
- 產業陷阱與挑戰
  - 實施成本高
  - 資料隱私和竊盜問題
成長潛力分析
監管環境
創新格局
啟動場景
波特的分析
PESTEL分析
未來市場趨勢
差距分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按組成部分，2021 - 2032 年

主要趨勢
服務
軟體

第 6 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
描述性的
預測性
規定性的

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
銷售和行銷支持
臨床試驗
研究與開發
監理合規性
供應鏈分析
藥物警戒

第 8 章：市場估計與預測：按部署模式，2021 - 2032 年

主要趨勢
基於雲端
本地

第 9 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
製藥和生物技術公司
合約研究組織
醫療器材製造商
其他最終用戶

第 10 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 11 章：公司簡介

Accenture
Analytics8
Cognizant
IBM Corporation
IQVIA Inc.
MaxisIT
Microsoft Corporation
Optum, Inc.
Oracle Corporation
SAS Institute, Inc.
Sisense Ltd.
ThoughtSpot Inc.
Veeva Systems
Veradigm LLC
Wipro Limited

簡介目錄

Product Code: 11045

The Global Life Science Analytics Market was valued at USD 15.7 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2032, fueled by the rising adoption of analytical solutions in clinical trials and the demand for personalized medicines.

One key driver is the increasing use of analytical solutions in clinical trials, addressing the growing complexity of clinical research. These solutions provide real-time insights, refine trial designs, and enhance decision-making, leading to more efficient outcomes. For example, a 2023 study by Pharma Intelligence found that 65% of clinical trial sponsors using advanced analytics saw a 25% boost in trial efficiency, including quicker patient recruitment and more precise data analysis.

Technological innovations are enhancing the efficiency of life science analytics. AI and machine learning integration refines predictive modeling and data interpretation, allowing meticulous analysis of vast datasets and revealing patterns that influence drug development and personalized treatment strategies.

The overall life science analytics industry is classified based on component, type, application, deployment mode, end-use, and region.

The services segment led the market with a revenue of USD 9.1 billion in 2023. Life sciences companies seek bespoke analytics solutions tailored to their research demands, regulatory standards, and data intricacies. Service providers design, implement, and manage these solutions, offering continuous support, updates, and maintenance to ensure optimal performance, bolstering the segment's growth.

In 2023, the sales and marketing support segment topped the revenue charts with USD 3.6 billion. Life sciences firms rely on analytics to gauge market trends, understand customer behavior, and assess competitive dynamics. Insights from sales and marketing analytics empower companies to craft targeted marketing strategies, refine sales approaches, and spot emerging market opportunities. Personalized, data-driven marketing enhances customer engagement and boosts conversion rates, propelling the segment's growth.

In 2023, North America dominated the life science analytics market with a revenue of USD 6.7 million and is projected to grow at a CAGR of 7.7% from 2024 to 2032. The region's advanced healthcare infrastructure facilitates the adoption of cutting-edge analytics solutions, allowing healthcare providers and life sciences firms to harness data analytics for better decision-making and patient outcomes. North America's substantial investments in R&D, especially in biotechnology and pharmaceuticals, amplify the demand for analytics tools that foster innovation and streamline drug development.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing adoption of analytical solutions in clinical trials
  - 3.2.1.2 Rising demand for personalized medicines
  - 3.2.1.3 Increasing penetration of analytics in life science industry
  - 3.2.1.4 Rise in technological advancements in analytical solutions
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High implementation cost
  - 3.2.2.2 Data privacy and theft issues
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Innovation landscape
3.6 Start-up scenario
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major key players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Services
5.3 Software

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Descriptive
6.3 Predictive
6.4 Prescriptive

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Sales and marketing support
7.3 Clinical trials
7.4 Research and development
7.5 Regulatory compliance
7.6 Supply chain analytics
7.7 Pharmacovigilance

Chapter 8 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Cloud-based
8.3 On-premises

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Pharmaceutical and biotech companies
9.3 Contract research organizations
9.4 Medical device manufacturers
9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa